Trademark Overview
On Thursday, July 10, 2025, a trademark application was filed for TRANSGENE with the United States Patent and Trademark Office. The USPTO has given the TRANSGENE trademark a serial number of 79429882. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 7, 2025. This trademark is owned by TRANSGENE. The TRANSGENE trademark is filed in the Pharmaceutical Products category with the following description:
Medicines; anti-cancer medicines; cancer treatment compounds; pharmaceutical preparations and substances for cancer treatment and/or prevention; immunotherapeutic products and agents in oncology; immunotherapeutic products and agents for bacterial infections; customized immunotherapy products; products to stimulate and modulate the immune system; oncolytic viruses; medicinal preparations and pharmaceutical preparations for the treatment of infectious or genetic diseases; pharmaceutical preparations for use in chemotherapy; chemotherapeutic agents; Pharmaceutical substances and preparations used in oncology; vaccines; cancer vaccines; therapeutic vaccines in oncology or genetics; viral vaccines; tumor antigens; viral antigens; vaccine adjuvant; Chemicals and biochemicals for medical and clinical use; agents and reagents for medical or clinical use; chemical or biochemical test kits; reagents for medical and clinical use comprising preparations, agents and reagents; Pharmaceutical produc...
